A New Path for Treating Brain Cancer With a Yale-developed Compound
Yale researchers have developed a new class of molecules that target some of the deadliest brain cancers while sparing healthy tissue. The discovery combines innovative synthetic chemistry and cutting-edge mechanistic studies in molecular biology, and offers a potentially powerful new approach to treating drug-resistant glioma tumors.
Yale New Haven Health Check: Advances in Radiation Therapy for Cancer
CT Style Host Natasha Lubczenko recently spoke with Dr. Melissa Young, a Radiation Oncologist at Bridgeport Hospital who specializes in Cancer Treatment. She spoke about recent advances in radiation therapy for cancer.Source: WTNH
Insights & Outcomes: Biofilms, cravings, and cells that spill their guts
Neutrophil extracellular traps (NETs) are important for health but if neutrophils go overboard and spill their guts too often, they can actually contribute to inflammatory diseases like cystic fibrosis, cancer, COVID-19, and more. Being able to calm neutrophils and rein in NETs could help treat these diseases. In a study recently published in the journal ImmunoHorizons, James E. Hansen, MD, MS, and his colleagues found that a certain lupus antibody can do just that.Source: YaleNews
Opioids and Cancer: How to Prevent and Manage Misuse
Since 1999, the opioid epidemic has claimed the lives of more than half a million people in the United States. Laws have been passed to limit the public’s access to opioids, but these laws may inadvertently affect patients who rely on prescription opioids to manage pain, particularly patients with cancer.Source: Cancer Therapy Advisor
Charted: How Patients Really Feel about AI in Health Care
Although most patients feel that artificial intelligence (AI) would improve health care, many still express concerns about potential consequences, including misdiagnoses and privacy breaches, according to a new study from Yale Cancer Center.Source: Advisory Board
Smilow Cancer Hospital Care Center at Trumbull physicians make ‘Top Docs’ list in Connecticut
Smilow Cancer Hospital Care Center at Trumbull physicians Michael Cohenuram, MD, Neal Fischbach, MD, David Witt, MD, Sajid Khan, MD, FACS, FSSO, Kevin Du, MD, PhD, and Saral Mehra, MD, MBA, FACS, are highlighted in the 2022 list of Top Doctors in Connecticut Magazine. Published in the magazine’s May issue, the 'Best Doctors' list includes physicians nominated by their peers.
How Do Patients Feel About Using AI in Health Care?
New research from Yale Cancer Center provides a new understanding of patients’ views of artificial intelligence (AI) in healthcare. While comfort level varied by clinical application, most respondents had positive views about AI’s ability to improve care. Concerns surfaced when potential for misdiagnosis, privacy breaches, reduced time with clinicians, and increased costs were discussed.
Hartford HealthCare, Yale New Haven Health receive approval to build Proton Center
Yale New Haven Health System (YNHHS) and Hartford HealthCare (HHC) today announced they have received final state approval to introduce proton beam therapy – a highly advanced form of radiation treatment for cancer – to Connecticut.
AACR Presents Awards to Further Diversity, Equity, and Inclusion in Cancer Research to Escobar-Hoyos Lab
The American Association for Cancer Research has presented two awards to further diversity, equity, and inclusion in cancer research to the Escobar-Hoyos Lab, under the direction of Luisa Escobar-Hoyos, MSc, PhD.